Influence of glucose on production and N-sulfation of heparan sulfate in cultured adipocyte cells

Molecular and Cellular Biochemistry

Volumn 213, Issue 1-2, 2000, Pages 1-9

  Parthasarathy, N ^a   Gotow, L F ^a   Bottoms, J D ^a   Obunike, J C ^b   Naggi, A ^c   Casu, B ^c   Goldberg, I J ^b   Wagner, W D ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b College of Physicians and Surgeons ^*  (United States)

^c Istituto di Ricerche Chimiche e Biochimiche G Ronzoni   (Italy)

Author keywords

Adipocytes; Heparan sulfate; Hyperglycaemia; Lipoprotein lipase; Sulfation

Indexed keywords

ACYLTRANSFERASE; GLUCOSE; HEPARAN SULFATE; LIPOPROTEIN LIPASE; N DEACETYLASE; SULFOTRANSFERASE; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CELL SURFACE; DIABETES MELLITUS; ENZYME REGULATION; HYPERTRIGLYCERIDEMIA; MOUSE; NONHUMAN; SULFATION;

ANIMALIA;

EID: 0033659163     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1007110700454     Document Type: Article

References (69)

1. Integral membrane heparan sulfate proteoglycans
2. Heparan sulfate: A piece of information
3. Patterns of sulfation in heparan sulfate: Polymorphism based on a common structural theme
4. 35S-glycopeptide metabolism by diabetic glomeruli and aorta
5. Alterations in basement membrane (heparan sulfate) proteoglycan in diabetic mice
6. 35S]sulfate incorporation into glomerular basement membrane glycosaminoglycans is decreased in experimental diabetes
7. Decreased de novo synthesis of glomerular proteoglycans in diabetes: Biochemical and autoradiographic evidence
8. 4 proteoglycans in streptozotocin-induced diabetic rats
9. Effect of diabetes on the glycosaminoglycan component of the human glomerular basement membrane
10. ECM gene expression and its modulation by insulin in diabetic rats
11. Reduced sulfation of liver heparan sulfate in experimentally induced diabetic rats
12. High glucose modifies heparan sulfate synthesis by mouse glomerular epithelial cells
13. Proteoglycan synthesis by human mesangial cells is depressed by hyperglycaemic glucose concentrations
14. The effect of glucose on proteoglycans produced by cultured mesangial cells
15. Lipoprotein lipase
16. Bensadoun A: Purification and characterization of adipocyte heparan sulfate proteoglycans with affinity for lipoprotein lipase
17. Lipoprotein lipase release from BFC-1 beta adipocytes. Effects of triglyceride-rich lipoproteins and lipolysis products
18. A form of acquired fat-induced lipemia
19. Plasma lipoprotein lipase in children with idiopathic nephrotic syndrome
20. Lipoprotein metabolism in nephrotic syndrome in childhood
21. Lipoprotein lipase in clinical and experimental nephrosis
22. Apolipoprotein CII and lipoprotein lipase in human nephrotic syndrome
23. Separation of a lipoprotein lipase cofactor from the alpha 1-acid glycoprotein from the urine of nephrotic patients
24. Inhibition of lipoprotein lipase by uremic plasma, a possible cause of hypertriglyceridemia
25. Lipoprotein composition as a component in the lipoprotein clearance defect in experimental diabetes
26. Nonenzymatic glycation of mesangial matrix and prolonged exposure of mesangial matrix to elevated glucose reduces collagen synthesis and proteoglycan charge
27. Regulation of lipoprotein lipase by glucose in primary cultures of isolated human adipocytes. Relevance to hypertriglyceridemia of diabetes
28. Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L 1 adipocytes
29. Distinct synthetic and structural characteristics of proteoglycans produced by cultured artery smooth muscle cells of atherosclerosis-susceptible pigeons
30. Characterization of novel sequences containing 3-O-sulfated glucosamine in glomerular basement membrane heparan sulfate and localization of sulfated disaccharides to a peripheral domain
31. Oligosaccharide sequences of human breast cancer cell heparan sulfate with high affinity for laminin
32. New method for quantitative determination of uronic acids
33. Structures and immunochemical properties of oligosaccharides isolated from pig submaxillary mucins
34. Structural characterization of the oligosaccharides formed by depolymerization of heparin with nitrous acid
35. Oligosaccharide sequences of endothelial cell surface heparan sulfate proteoglycan with affinity for lipoprotein lipase
36. A method for the determination of the molecular weight and molecular weight distribution of chondroitin sulfate
37. Altered dermatan sulfate structure and reduced heparin cofactor II stimulating activity of biglycan and decorin from human atherosclerotic plaque
38. An animal cell mutant defective in heparan sulfate hexuronic acid 2-O-sulfation
39. Synthesis of sulfated oligosaccharides by cystic fibrosis trachea epithelial cells
40. Undersulfated heparan sulfate in a Chinese hamster ovary cell mutant deficient in heparan sulfate N-sulfotransferase
41. Purification, photoaffinity labeling, characterization of a single enzyme for 6-O-sulfation of both chondroitin sulfate and keratan sulfate
42. Molecular cloning and expression of rat liver N-heparan sulfate sulfotransferase
43. Ribosomal DNA. Molecular evolution and phylogenetic inference
44. Preparation of a homogeneous and stable form of bovine milk lipoprotein lipase
45. Minimal sequence of heparin/heparan sulfate required for binding of basic fibroblast growth factor
46. Insulin regulation of lipoprotein lipase in cultured isolated rat adipocytes
47. Localization of lipase-like immunoreactivity in porcine adipose, aortic and myocardial tissue
48. Immunohistochemical localization of lipoprotein lipase in adipose tissue
49. Release of lipoprotein lipase activity from isolated fat cells. II. Effect of heparin
50. Lipoprotein lipase: Cellular origin and functional distribution
51. Secretion and degradation of lipoprotein lipase in cultured adipocytes. Binding of lipoprotein lipase to membrane heparan sulfate proteoglycans is necessary for degradation
52. Structural characterization of heparan sulfate proteoglycan subclasses isolated from bovine aortic endothelial cell cultures
53. Isolation and characterization of ryudocan and syndecan heparan sulfate proteoglycans, core proteins, and cDNAs from a rat endothelial cell line
54. Diabetes reduces heparin- and phospholipase C-releasable lipoprotein lipase from cardiac myocytes
55. Insulin-stimulated release of lipoprotein lipase by metabolism of its phosphatidylinositol anchor
56. Phosphatidylinositol-specific phospholipase C releases lipoprotein lipase from the heparin releasable pool in rat heart cell cultures
57. Effect of chlorate on the sulfation of lipoprotein lipase and heparan sulfate proteoglycans. Sulfation of heparan sulfate proteoglycans affects lipoprotein lipase degradation
58. Structure and biosynthesis of heparin-like polysaccharides
59. Glucosaminyl N-deacetylase in cultured fibroblasts: Comparison of patients with and without diabetic nephropathy, and identification of a possible mechanism for diabetes-induced N-deacetylase inhibition
60. Inhibition of glucosaminyl N-deacetylase in diabetic rats
61. Diabetes mellitus induced inhibition of glucosaminyl N-deacetylase: Effect of short-term blood glucose control in diabetic rats
62. Transitory effects of glucose starvation on the synthesis of dolichol-linked oligosaccharides in mammalian cells
63. Glucose starvation alters lipid-linked oligosaccharide biosynthesis in Chinese hamster ovary cells
64. Regulation of lipoprotein lipase in the diabetic rat
65. Insulin increases the synthetic rate and messenger RNA level of lipoprotein lipase in isolated rat adipocytes
66. Insulin regulation of lipoprotein lipase activity and release in 3T3-L1 adipocytes. Separation and dependence of hormonal effects on hexose metabolism and synthesis of RNA and protein
67. Tumor metastasis-associated heparanase (heparan sulfate endoglycosidase) activity in human melanoma cells
68. Delayed catabolism of apoB48 lipoproteins in streptozotocin-treated mice: Evidence that diabetes leads to a selective alteration in the heparan sulfate proteoglycan pathway of chylomicron remnant degradation